Loading data for SER — first visit, this takes a few seconds.
Serina Therapeutics Inc. (SER)
NYSE American: SER
· 실시간 가격 · USD
2.61
-0.01 (-0.38%)
종가 기준: Aug 18, 2026, 8:00 PM
Serina Therapeutics Inc. (SER) Stock Price, Analysis & Data
-0.38% (1D)
데이터 없음
SER 소개
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early ...
전체 기업 정보재무 실적
2025년 Serina Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -19.18M로, 72.17% 증가했습니다.
재무제표어닝 서프라이즈
Serina Therapeutics가 Aug 13, 2026에 분기 실적을 발표했습니다:
